Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Lecomte

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Ambio|July 24, 2019
Documenting lemming population change in the Arctic: Can we detect trends?Dorothée Ehrich, Niels M Schmidt, Gilles Gauthier, et al.
Global Change Biology|September 11, 2020
Parasitoids indicate major climate-induced shifts in arctic communitiesTuomas Kankaanpää, Eero Vesterinen, Bess Hardwick, et al.
Cancer Cell|June 20, 2020
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic CancerLuisa F Escobar-Hoyos, Alex Penson, Ram Kannan, et al.
Movement Ecology|May 3, 2016
Effects of geolocators on hatching success, return rates, breeding movements, and change in body mass in 16 species of Arctic-breeding shorebirdsEmily L Weiser, Richard B Lanctot, Stephen C Brown, et al.
Research Square|September 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II TrialWungki Park, Catherine O'Connor, Joanne Chou, et al.
Nature|April 30, 2025
Plant diversity dynamics over space and time in a warming ArcticMariana García Criado, Isla H Myers-Smith, Anne D Bjorkman, et al.
Nature Medicine|March 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trialWungki Park, Catherine A O'Connor, Joanne F Chou, et al.
Science (New York, N.Y.)|June 15, 2019
Comment on "Global pattern of nest predation is disrupted by climate change in shorebirds"Martin Bulla, Jeroen Reneerkens, Emily L Weiser, et al.
Cell|March 31, 2026
A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapyZeda Zhang, Yu-Jui Ho, Xin Fang, et al.
Cancer Discovery|June 2, 2018
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic CancerHervé Tiriac, Pascal Belleau, Dannielle D Engle, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Ambio|July 24, 2019
Documenting lemming population change in the Arctic: Can we detect trends?Dorothée Ehrich, Niels M Schmidt, Gilles Gauthier, et al.
Global Change Biology|September 11, 2020
Parasitoids indicate major climate-induced shifts in arctic communitiesTuomas Kankaanpää, Eero Vesterinen, Bess Hardwick, et al.
Cancer Cell|June 20, 2020
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic CancerLuisa F Escobar-Hoyos, Alex Penson, Ram Kannan, et al.
Movement Ecology|May 3, 2016
Effects of geolocators on hatching success, return rates, breeding movements, and change in body mass in 16 species of Arctic-breeding shorebirdsEmily L Weiser, Richard B Lanctot, Stephen C Brown, et al.
Research Square|September 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II TrialWungki Park, Catherine O'Connor, Joanne Chou, et al.
Nature|April 30, 2025
Plant diversity dynamics over space and time in a warming ArcticMariana García Criado, Isla H Myers-Smith, Anne D Bjorkman, et al.
Nature Medicine|March 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trialWungki Park, Catherine A O'Connor, Joanne F Chou, et al.
Science (New York, N.Y.)|June 15, 2019
Comment on "Global pattern of nest predation is disrupted by climate change in shorebirds"Martin Bulla, Jeroen Reneerkens, Emily L Weiser, et al.
Cell|March 31, 2026
A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapyZeda Zhang, Yu-Jui Ho, Xin Fang, et al.
Cancer Discovery|June 2, 2018
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic CancerHervé Tiriac, Pascal Belleau, Dannielle D Engle, et al.
Pageof 9